Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder

Blood

Volumn 123, Issue 23, 2014, Pages 3651-3654

  Warkentin, Theodore E ^a   Basciano, Paul A ^b   Knopman, Jared ^b   Bernstein, Richard A ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARGATROBAN; FONDAPARINUX; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN INFARCTION; CASE REPORT; CEREBROVASCULAR ACCIDENT; EMERGENCY WARD; ENZYME IMMUNOASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LEG SWELLING; LIMB WEAKNESS; LOWER EXTREMITY DEEP VEIN THROMBOSIS; MALE; MIDDLE AGED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR INFERIOR CEREBELLAR ARTERY; PRIORITY JOURNAL; SEROTONIN RELEASE; SHOULDER HEMIARTHROPLASTY; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; VASCULAR PATENCY;

ANTIBODIES; ANTICOAGULANTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPARIN; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; SYNDROME; THROMBOCYTOPENIA;

EID: 84902199328     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-01-549741     Document Type: Article

References (22)

1. Kelton JG, Arnold DM, Bates SM. Nonheparin anticoagulants for heparin-induced thrombocytopenia. N Engl J Med. 2013;368(8): 737-744.
2. Bakchoul T, Greinacher A. Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia. Ther Adv Hematol. 2012;3(4): 237-251.
3. Warkentin TE, Kelton JG. Delayed-onset heparininduced thrombocytopenia and thrombosis. Ann Intern Med. 2001;135(7):502-506.
4. Warkentin TE, Makris M, Jay RM, Kelton JG. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia. Am J Med. 2008;121(7):632-636. (Pubitemid 351876183)
5. Jay RM, Warkentin TE. Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of 'spontaneous' HIT? J Thromb Haemost. 2008;6(9):1598-1600.
6. Pruthi RK, Daniels PR, Nambudiri GS, Warkentin TE. Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery 'spontaneous' HIT. J Thromb Haemost. 2009;7(3):499-501.
7. Ketha S, Smithedajkul P, Vella A, Pruthi R, Wysokinski W, McBane R. Adrenal haemorrhage due to heparin-induced thrombocytopenia. Thromb Haemost. 2013;109(4):669-675.
8. Warkentin TE, Maurer BT, Aster RH. Heparininduced thrombocytopenia associated with fondaparinux. N Engl J Med. 2007;356(25): 2653-2655, discussion 2653-2655.
9. Rota E, Bazzan M, Fantino G. Fondaparinuxrelated thrombocytopenia in a previous lowmolecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT). Thromb Haemost. 2008;99(4):779-781. (Pubitemid 351694236)
10. Salem M, Elrefai S, Shrit MA, Warkentin TE. Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke. Thromb Haemost. 2010;104(5):1071- 1072.
11. Burch M, Cooper B. Fondaparinux-associated heparin-induced thrombocytopenia. Proc (Bayl Univ Med Cent). 2012;25(1):13-15.
12. Warkentin TE, Chakraborty AK, Sheppard JA, Griffin DK. The serological profile of fondaparinuxassociated heparin-induced thrombocytopenia syndrome. Thromb Haemost. 2012;108(2): 394-396.
13. Warkentin TE, Sheppard JI, Moore JC, Kelton JG. The use of well-characterized sera for the assessment of new diagnostic enzymeimmunoassays for the diagnosis of heparininduced thrombocytopenia. J Thromb Haemost. 2010;8(1):216-218.
14. Visentin GP, Moghaddam M, Beery SE, McFarland JG, Aster RH. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis. J Lab Clin Med. 2001;138(1):22-31. (Pubitemid 32589199)
15. Warkentin TE, Hayward CPM, Smith CA, Kelly PM, Kelton JG. Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med. 1992;120(3): 371-379.
16. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001;344(17):1286-1292. (Pubitemid 32372963)
17. Ortel TL, Kitchens CS, Erkan D, et al. Clinical causes and treatment of the thrombotic storm. Expert Rev Hematol. 2012;5(6):653-659.
18. Perrin J, Barraud D, Toussaint-Hacquard M, Bollaert PE, Lecompte T. Rapid onset heparininduced thrombocytopenia (HIT) without history of heparin exposure: a new case of so-called 'spontaneous' HIT. Thromb Haemost. 2012; 107(4):795-797.
19. Krauel K, Pötschke C, Weber C, et al. Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. Blood. 2011; 117(4):1370-1378.
20. Jaax ME, Krauel K, Marschall T, et al. Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4. Blood. 2013;122(2):272-281.
21. Pongas G, Dasgupta SK, Thiagarajan P. Antiplatelet factor 4/heparin antibodies in patients with gram negative bacteremia. Thromb Res. 2013;132(2):217-220.
22. Greinacher A, Michels I, Kiefel V, Mueller- Eckhardt C. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost. 1991;66(6):734-736.